Free Trial

bluebird bio (BLUE) Insider Trading & Ownership

bluebird bio logo
$4.08 -2.96 (-42.05%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$4.00 -0.08 (-1.96%)
As of 02/21/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

bluebird bio (NASDAQ:BLUE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.40%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$3,233.92
Get BLUE Insider Trade Alerts

Want to know when executives and insiders are buying or selling bluebird bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BLUE Insider Buying and Selling by Quarter

bluebird bio Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/3/2025Andrew ObenshainCEOSell86$7.39$635.54  
2/3/2025Thomas J KlimaInsiderSell122$7.39$901.58  
1/6/2025Andrew ObenshainCEOSell140$9.24$1,293.60  
12/10/2024Andrew ObenshainCEOSell48$8.40$403.20  
(Data available from 1/1/2013 forward)

BLUE Insider Trading Activity - Frequently Asked Questions

The list of insiders at bluebird bio includes Andrew Obenshain, Anne-Virginie Eggimann, Christopher Krawtschuk, Jason Cole, Nick Leschly, Richard A Colvin, and Thomas J Klima. Learn more on insiders at BLUE.

1.40% of bluebird bio stock is owned by insiders. Learn more on BLUE's insider holdings.

The following insiders have sold BLUE shares in the last 24 months: Andrew Obenshain ($68,421.94), Christopher Krawtschuk ($20,430.40), Richard A Colvin ($823.60), and Thomas J Klima ($21,238.38).

Insiders have sold a total of 2,135 bluebird bio shares in the last 24 months for a total of $110,914.32 sold.

bluebird bio Key Executives

  • Mr. Andrew  ObenshainMr. Andrew Obenshain (Age 50)
    President, CEO & Director
    Compensation: $1.04M
    3 recent trades
  • Mr. Thomas J. Klima (Age 52)
    Chief Commercial Officer & COO
    Compensation: $654.97k
    1 recent trades
  • Mr. Richard A. Colvin M.D. (Age 58)
    Ph.D., Chief Medical Officer
    Compensation: $696.24k
  • Mr. Oliver James Sterling III
    CFO & Principal Accounting Officer
  • Mr. Joseph D. Vittiglio Esq. (Age 52)
    J.D., Chief Legal & Business Officer and Secretary
  • Jess Rowlands
    Head of Corporate Communications
  • Ms. Andrea Walton
    Chief People Officer
  • Mr. Kasra Kasraian
    Senior Vice President of Technical Development & Operations
  • Mr. Scott Shoemaker
    Senior Vice President of Quality
  • Ms. Sarah Alspach
    Senior Vice President of External Affairs


This page (NASDAQ:BLUE) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners